PT728002E - Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano - Google Patents

Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano

Info

Publication number: PT728002E
Authority: PT; Portugal
Prior art keywords: infection; treatment; prophylaxia; herpes; purine derivatives
Prior art date: 1993-11-12

Application number

PT95900830T

Other languages

English (en)

Inventor

Richard Anthony Vere Hodge

Original Assignee

Novartis Int Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-12

Filing date

1994-11-11

Publication date

2002-05-31

1994-11-11 Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd

2002-05-31 Publication of PT728002E publication Critical patent/PT728002E/pt

Links

238000011282 treatment Methods 0.000 title abstract 2
150000005019 2-aminopurines Chemical class 0.000 title 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 1
241000700605 Viruses Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
208000037773 HHV-7 infectious disease Diseases 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
-1 phosphate ester Chemical class 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)

PT95900830T 1993-11-12 1994-11-11 Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano PT728002E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939323404A GB9323404D0 (en)	1993-11-12	1993-11-12	Pharmaceuticals

Publications (1)

Publication Number	Publication Date
PT728002E true PT728002E (pt)	2002-05-31

Family

ID=10745092

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95900830T PT728002E (pt)	1993-11-12	1994-11-11	Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano

Country Status (17)

Country	Link
US (1)	US6051579A (pt)
EP (1)	EP0728002B1 (pt)
JP (1)	JP3821840B2 (pt)
KR (1)	KR100341736B1 (pt)
CN (1)	CN1071572C (pt)
AT (1)	ATE210445T1 (pt)
AU (1)	AU696833B2 (pt)
CA (1)	CA2176392C (pt)
CY (1)	CY2337B1 (pt)
DE (1)	DE69429447T2 (pt)
DK (1)	DK0728002T3 (pt)
ES (1)	ES2169117T3 (pt)
GB (1)	GB9323404D0 (pt)
PT (1)	PT728002E (pt)
SI (1)	SI0728002T1 (pt)
WO (1)	WO1995013074A1 (pt)
ZA (1)	ZA948908B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6475253B2 (en)	1996-09-11	2002-11-05	3M Innovative Properties Company	Abrasive article and method of making
CA2496684A1 (en) *	2002-08-26	2004-03-04	Teva Pharmaceutical Industries Ltd	Crystalline solid famciclovir forms i, ii, iii and preparation thereof
KR101354995B1 (ko) *	2005-09-08	2014-01-23	사이단호진한다이비세이부쯔뵤우겐큐우카이	임파구계 혈구계 세포에 유전자 도입을 위한 프로모터 및 그의 이용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0141927B1 (en) *	1983-08-18	1991-10-30	Beecham Group Plc	Antiviral guanine derivatives
DE3582399D1 (de) *	1984-09-20	1991-05-08	Beecham Group Plc	Purin-derivate und ihre pharmazeutische verwendung.
DE3671227D1 (de) *	1985-07-27	1990-06-21	Beecham Group Plc	9-substituierte guaninmonohydrate.
GB8628826D0 (en) *	1986-12-02	1987-01-07	Beecham Group Plc	Pharmaceutical products
US4795799A (en) *	1987-09-08	1989-01-03	Phillips Petroleum Company	Production of aromatic sulfide/ketone polymers with alkali metal carbonate
AU635642B2 (en) *	1990-05-24	1993-03-25	E.R. Squibb & Sons, Inc.	Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) *	1990-07-07	1990-08-29	Beecham Group Plc	Pharmaceutical treatment

1993
- 1993-11-12 GB GB939323404A patent/GB9323404D0/en active Pending
1994
- 1994-11-10 ZA ZA948908A patent/ZA948908B/xx unknown
- 1994-11-11 DK DK95900830T patent/DK0728002T3/da active
- 1994-11-11 EP EP95900830A patent/EP0728002B1/en not_active Expired - Lifetime
- 1994-11-11 WO PCT/GB1994/002486 patent/WO1995013074A1/en not_active Ceased
- 1994-11-11 DE DE69429447T patent/DE69429447T2/de not_active Expired - Lifetime
- 1994-11-11 SI SI9430409T patent/SI0728002T1/xx unknown
- 1994-11-11 AU AU81491/94A patent/AU696833B2/en not_active Ceased
- 1994-11-11 AT AT95900830T patent/ATE210445T1/de active
- 1994-11-11 KR KR1019960702484A patent/KR100341736B1/ko not_active Expired - Fee Related
- 1994-11-11 CN CN94194328A patent/CN1071572C/zh not_active Expired - Fee Related
- 1994-11-11 JP JP51369795A patent/JP3821840B2/ja not_active Expired - Fee Related
- 1994-11-11 ES ES95900830T patent/ES2169117T3/es not_active Expired - Lifetime
- 1994-11-11 CA CA002176392A patent/CA2176392C/en not_active Expired - Fee Related
- 1994-11-11 PT PT95900830T patent/PT728002E/pt unknown
1998
- 1998-12-10 US US09/209,666 patent/US6051579A/en not_active Expired - Lifetime
2003
- 2003-03-11 CY CY0300023A patent/CY2337B1/xx unknown

Also Published As

Publication number	Publication date
CA2176392A1 (en)	1995-05-18
DE69429447T2 (de)	2002-07-25
CN1136277A (zh)	1996-11-20
GB9323404D0 (en)	1994-01-05
JPH09511218A (ja)	1997-11-11
DK0728002T3 (da)	2002-04-08
ATE210445T1 (de)	2001-12-15
KR100341736B1 (ko)	2002-11-23
CA2176392C (en)	2005-11-08
EP0728002B1 (en)	2001-12-12
WO1995013074A1 (en)	1995-05-18
ZA948908B (en)	1995-08-17
AU696833B2 (en)	1998-09-17
AU8149194A (en)	1995-05-29
SI0728002T1 (en)	2002-04-30
JP3821840B2 (ja)	2006-09-13
CY2337B1 (en)	2004-02-06
US6051579A (en)	2000-04-18
EP0728002A1 (en)	1996-08-28
ES2169117T3 (es)	2002-07-01
CN1071572C (zh)	2001-09-26
HK1012234A1 (en)	1999-07-30
DE69429447D1 (de)	2002-01-24

Publication	Publication Date	Title
DE69318031D1 (de)	1998-05-20	Ematiomerenreine beta-d-dioxolane nucleoside mit selektiver antihepatitis b-virus wirkung
SE8801729D0 (sv)	1988-05-06	Purine derivatives for use in therapy
ES2037095T3 (es)	1993-06-16	Un procedimiento para preparar una composicion farmaceutica.
LV10923A (lv)	1995-12-20	Penciklovira atvasinajumi hepatita-B infekciju arstesanai
AU8447991A (en)	1992-03-30	Antineoplastic effect potentiator and antineoplastic agent
CY2337B1 (en)	2004-02-06	Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection.
BG101608A (en)	1998-02-27	The use of aminopurine antiviral means for the treatment and prophylaxy of latent infections caused by herpes viruses
CY2338B1 (en)	2004-02-06	Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections.
IL111138A (en)	1997-04-15	Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
BR9607663A (pt)	1998-06-16	Uso de penciclovir para o tratamento de herpes-virus 8 humano